Parmax Pharma Ltd vs Shree Ganesh Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Parmax Pharma Ltd is ₹ 31.17 as of 15 May 15:30 . The P/E Ratio of Parmax Pharma Ltd is 0 as of March 2024 .The P/E Ratio of Shree Ganesh Remedies Ltd is 30.5 as of March 2024 . The Market Cap of Parmax Pharma Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Shree Ganesh Remedies Ltd is ₹ 801.21 crore as of March 2024 . The revenue of Parmax Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shree Ganesh Remedies Ltd for the Mar '26 is ₹ 34.22 crore as compare to the Dec '25 revenue of ₹ 21.76 crore. This represent the growth of 57.26% The ebitda of Parmax Pharma Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shree Ganesh Remedies Ltd for the Mar '26 is ₹ 12.4 crore as compare to the Dec '25 ebitda of ₹ 7.39 crore. This represent the growth of 67.79% The net profit of Parmax Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Shree Ganesh Remedies Ltd changed from ₹ 4.65 crore to ₹ 6.27 crore over 8 quarters. This represents a CAGR of 16.12% The Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shree Ganesh Remedies Ltd changed from 17.97 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Parmax Pharma Ltd

Incorporated in November, 1994, Parmax Pharma Limited (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations.
The Company has manufacturing facilities approved by Indian regulatory bodies such as CDSCO, State FDA, and operates under GMP-compliant systems. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

About Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name 'Shree Ganesh Remedies Private Limited' at Ahmedabad, Gujarat on April 27, 1995.
Subsequently the Company was converted into a Public Limited and the name of the Company was changed to 'Shree Ganesh Remedies Limited' on July 28, 2017.
The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals. Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.
The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.

FAQs for the comparison of Parmax Pharma Ltd and Shree Ganesh Remedies Ltd

Which company has a larger market capitalization, Parmax Pharma Ltd or Shree Ganesh Remedies Ltd?

Market cap of Parmax Pharma Ltd is 11 Cr while Market cap of Shree Ganesh Remedies Ltd is 738 Cr

What are the key factors driving the stock performance of Parmax Pharma Ltd and Shree Ganesh Remedies Ltd?

The stock performance of Parmax Pharma Ltd and Shree Ganesh Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Parmax Pharma Ltd and Shree Ganesh Remedies Ltd?

As of May 18, 2026, the Parmax Pharma Ltd stock price is INR ₹31.17. On the other hand, Shree Ganesh Remedies Ltd stock price is INR ₹575.6.

How do dividend payouts of Parmax Pharma Ltd and Shree Ganesh Remedies Ltd compare?

To compare the dividend payouts of Parmax Pharma Ltd and Shree Ganesh Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.